Published in Drug Law Weekly, January 26th, 2010
Under the terms of the agreement, Novartis will make upfront cash and equity investments in Proteus totaling US$24 million. Proteus would also receive royalties on worldwide net...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.